News from the FDA/CDC
News from the FDA/CDC
Margetuximab approved for HER2-positive metastatic breast cancer
The monoclonal antibody margetuximab-cmkb demonstrated superiority over trastuzumab.
News from the FDA/CDC
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.
News
FDA safety alert: Face masks with metal can burn during MRI
News from the FDA/CDC
FDA approves first agent for PSMA-PET imaging in prostate cancer
The diagnostic agent Gallium 68 PSMA-11 has been approved for institutional use only.
News from the FDA/CDC
New drug approved for relapsed/refractory neuroblastoma
News
CDC panel delves into priorities for COVID vaccine distribution
News
FDA authorizes baricitinib combo for COVID-19
News
FDA approves first at-home COVID-19 test kit
The Lucira COVID-19 All-In-One Test-Kit is a single-use test that has a nasal swab to collect samples for people ages 14 and older.
News
Pembrolizumab approved for triple-negative breast cancer
This is the first breast cancer indication for pembrolizumab.
News
Nearly 10% of hospitalized patients with COVID-19 later readmitted
News from the FDA/CDC
CDC panel takes on COVID vaccine rollout, risks, and side effects
ACIP will need to offer direction on which groups should get priority in vaccine allocation, inasmuch as early supplies will not be sufficient to...